liaison

Full time IQVIA, società leader a livello globale nei servizi dedicati alle aziende del settore farmaceutico e biotecnologico, è attualmente alla ricerca di un/una Professionista nell’ambito dell’Informazione Scientifica del Farmaco da inserire nelle zone di interesse. Le figure selezionate saranno coinvolte in un progetto strategico di rilievo,...

Informatore Scientifico del Farmaco-Trapani/AG### Informatore Scientifico del Farmaco-Trapani/AGApply: Milan, Italy: Full time: Posted Today: R1576205IQVIA, società leader a livello globale nei servizi dedicati alle aziende del settore farmaceutico e biotecnologico, è attualmente alla ricerca di un/una Professionista nell'ambito dell'Informazione...

Informatore Scientifico del Farmaco-Trapani/AG### Informatore Scientifico del Farmaco-Trapani/AGApply: Milan, Italy: Full time: Posted Today: R1576205IQVIA, società leader a livello globale nei servizi dedicati alle aziende del settore farmaceutico e biotecnologico, è attualmente alla ricerca di un/una Professionista nell'ambito dell'Informazione...

Informatore Scientifico del Farmaco-Trapani/AG### Informatore Scientifico del Farmaco-Trapani/AGApply: Milan, Italy: Full time: Posted Today: R1576205IQVIA, società leader a livello globale nei servizi dedicati alle aziende del settore farmaceutico e biotecnologico, è attualmente alla ricerca di un/una Professionista nell'ambito dell'Informazione...

Site Engagement LiaisonSe le sue competenze, la sua esperienza e le sue qualifiche corrispondono a quelle descritte in questa panoramica, non ritardi l'invio della sua candidatura.At ICON Strategic Solutions, you will work in a sponsor-dedicated model, supported by ICON’s global expertise.As the world’s largest FSP organisation, with over 90 sponsor...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Site Engagement LiaisonSe le sue competenze, la sua esperienza e le sue qualifiche corrispondono a quelle descritte in questa panoramica, non ritardi l'invio della sua candidatura.At ICON Strategic Solutions, you will work in a sponsor-dedicated model, supported by ICON’s global expertise.As the world’s largest FSP organisation, with over 90 sponsor...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Site Engagement LiaisonSe le sue competenze, la sua esperienza e le sue qualifiche corrispondono a quelle descritte in questa panoramica, non ritardi l'invio della sua candidatura.At ICON Strategic Solutions, you will work in a sponsor-dedicated model, supported by ICON’s global expertise.As the world’s largest FSP organisation, with over 90 sponsor...

Site Engagement LiaisonSe le sue competenze, la sua esperienza e le sue qualifiche corrispondono a quelle descritte in questa panoramica, non ritardi l'invio della sua candidatura.At ICON Strategic Solutions, you will work in a sponsor-dedicated model, supported by ICON’s global expertise.As the world’s largest FSP organisation, with over 90 sponsor...

Site Engagement LiaisonSe le sue competenze, la sua esperienza e le sue qualifiche corrispondono a quelle descritte in questa panoramica, non ritardi l'invio della sua candidatura.At ICON Strategic Solutions, you will work in a sponsor-dedicated model, supported by ICON’s global expertise.As the world’s largest FSP organisation, with over 90 sponsor...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

Quetzal Therapeutics is a biopharmaceutical company focused on the development of treatment for rare diseases including hematologic malignancies. The company’s lead product is QTX-2101, a novel paradigm for treating patients with Acute Promyelocytic Leukemia (APL) for which the company initiated a Phase III clinical trial in December 2025. Quetzal is also...

At ICON Strategic Solutions, you will work in a sponsor-dedicated model, supported by ICON’s global expertise. As the world’s largest FSP organisation, with over 90 sponsor partnerships, we offer stability, career development and a collaborative environment where your work contributes to the development of treatments that benefit patients worldwide. As a...

Overview As a Site Engagement Liaison, you will cultivate strong site relationships to support clinical trials and drive site engagement across sponsor partnerships. You will work closely with investigators, site staff, and internal teams to ensure study conduct and regulatory compliance while identifying opportunities to optimize site performance. The role...